The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron
Open accessAbstract
Humans have two nearly identical copies of the Survival Motor Neuron (SMN) gene, SMN1 and SMN2. In spinal muscular atrophy (SMA), SMN2 is not able to compensate for the loss of SMN1 due to exclusion of exon 7. Here we describe a novel inhibitory element located immediately downstream of the 5' splice site in intron 7. We call this element intronic splicing silencer N1 (ISS-N1). Deletion of ISS-N1 promoted exon 7 inclusion in mRNAs derived from the SMN2 minigene. Underlining the dominant role of ISS-N1 in exon 7 skipping, abrogation of a number of positive cis elements was tolerated when ISS-N1 was deleted. Confirming the silencer function of ISS-N1, an antisense oligonucleotide against ISS-N1 restored exon 7 inclusion in mRNAs derived from the SMN2 minigene or from endogenous SMN2. Consistently, this oligonucleotide increased the levels of SMN protein in SMA patient-derived cells that carry only the SMN2 gene. Our findings underscore for the first time the profound impact of an evolutionarily nonconserved intronic element on SMN2 exon 7 splicing. Considering that oligonucleotides annealing to intronic sequences do not interfere with exon-junction complex formation or mRNA transport and translation, ISS-N1 provides a very specific and efficient therapeutic target for antisense oligonucleotide-mediated correction of SMN2 splicing in SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Mechanisms of Alternative Pre-Messenger RNA Splicing
Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704
ESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Self-citationPre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Analysis of gene function in somatic mammalian cells using small interfering RNAs
Elbashir, S. (2002) · Methods · doi:10.1016/s1046-2023(02)00023-3 · Cited by 1,095
Sorting out the complexity of SR protein functions
GRAVELEY, B. R. (2000) · RNA · doi:10.1017/s1355838200000960 · Cited by 1,078
Predictive Identification of Exonic Splicing Enhancers in Human Genes
Fairbrother, W. G., Yeh, R.-F., Sharp, P. A., & Burge, C. B. (2002) · Science · doi:10.1126/science.1073774 · Cited by 1,036
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Alternative pre-mRNA splicing and proteome expansion in metazoans
Maniatis, T., & Tasic, B. (2002) · Nature · doi:10.1038/418236a · Cited by 768
Cartegni, L., & Krainer, A. R. (2002) · Nature Genetics · doi:10.1038/ng854 · Cited by 730
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
A mouse model for spinal muscular atrophy
Hsieh-Li, H. M., Chang, J.-G., Jong, Y.-J., Wu, M.-H., Wang, N. M., Tsai, C. H., & Li, H. (2000) · Nature Genetics · doi:10.1038/71709 · Cited by 702
Systematic Identification and Analysis of Exonic Splicing Silencers
Wang, Z., Rolish, M. E., Yeo, G., Tung, V., Mawson, M., & Burge, C. B. (2004) · Cell · doi:10.1016/j.cell.2004.11.010 · Cited by 693
Genomic variants in exons and introns: identifying the splicing spoilers
Pagani, F., & Baralle, F. E. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1327 · Cited by 606
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
Kashima, T., & Manley, J. L. (2003) · Nature Genetics · doi:10.1038/ng1207 · Cited by 546
Alternative splicing in disease and therapy
Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L. (2004) · Nature Biotechnology · doi:10.1038/nbt964 · Cited by 527
SMN oligomerization defect correlates with spinal muscular atrophy severity
Lorson, C. L., Strasswimmer, J., Yao, J.-M., Baleja, J. D., Hahnen, E., Wirth, B., Le, T., Burghes, A. H. M., & Androphy, E. J. (1998) · Nature Genetics · doi:10.1038/ng0598-63 · Cited by 500
Self-citationRules of engagement: co-transcriptional recruitment of pre-mRNA processing factors
Bentley, D. L. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.006 · Cited by 486
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
Lorson, C. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.259 · Cited by 435
Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process
Buratti, E., & Baralle, F. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10505-10514.2004 · Cited by 427
Computational definition of sequence motifs governing constitutive exon splicing
Zhang, X. H.-F., & Chasin, L. A. (2004) · Genes & Development · doi:10.1101/gad.1195304 · Cited by 419
Nott, A., Le Hir, H., & Moore, M. J. (2004) · Genes & Development · doi:10.1101/gad.1163204 · Cited by 410
Lu, Q. L., Rabinowitz, A., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G., & Partridge, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406700102 · Cited by 402
The spliceosome: the most complex macromolecular machine in the cell?
Nilsen, T. W. (2003) · BioEssays · doi:10.1002/bies.10394 · Cited by 378
Nanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
Regulation of Fas Alternative Splicing by Antagonistic Effects of TIA-1 and PTB on Exon Definition
Izquierdo, J. M., Majós, N., Bonnal, S., Martínez, C., Castelo, R., Guigó, R., Bilbao, D., & Valcárcel, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.015 · Cited by 364
Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J., & Wirth, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160181697 · Cited by 314
Self-citationCorrection of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
Intronic Sequences Flanking Alternatively Spliced Exons Are Conserved Between Human and Mouse
Sorek, R., & Ast, G. (2003) · Genome Research · doi:10.1101/gr.1208803 · Cited by 278
Skordis, L. A., Dunckley, M. G., Yue, B., Eperon, I. C., & Muntoni, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633863100 · Cited by 274
Promoter usage and alternative splicing
Kornblihtt, A. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.014 · Cited by 236
Mercado, P. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki897 · Cited by 225
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19547 · Cited by 207
Clark, F. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.451 · Cited by 203
Pagani, F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg131 · Cited by 199
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319547 · Cited by 198
Hofmann, Y. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.2037 · Cited by 193
Wan, L., Battle, D. J., Yong, J., Gubitz, A. K., Kolb, S. J., Wang, J., & Dreyfuss, G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5543-5551.2005 · Cited by 185
Mercatante, D. R., Mohler, J. L., & Kole, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209236200 · Cited by 174
Lim, S. R., & Hertel, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107632200 · Cited by 159
Young, P. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.577 · Cited by 143
Pagani, F., Buratti, E., Stuani, C., & Baralle, F. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212813200 · Cited by 141
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · RNA · doi:10.1261/rna.7580704 · Cited by 140
Self-citationCrooke, S. T. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360375 · Cited by 139
Helmken, C., Hofmann, Y., Schoenen, F. J., Oprea, G. E., Raschke, H., Rudnik-Sch�neborn, S., Zerres, K., & Wirth, B. (2003) · Human Genetics · doi:10.1007/s00439-003-1025-2 · Cited by 125
Genes for SMA: Multum in parvo
Lewin, B. (1995) · Cell · doi:10.1016/0092-8674(95)90442-5 · Cited by 119
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.067 · Cited by 117
Self-citationIdentification of a Cis-acting Element for the Regulation ofSMN Exon 7 Splicing
Miyajima, H., Miyaso, H., Okumura, M., Kurisu, J., & Imaizumi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200851200 · Cited by 104
Dichotomous splicing signals in exon flanksPreprint
Zhang, X. H.-F., Leslie, C. S., & Chasin, L. A. (2005) · Genome Research · doi:10.1101/gr.3217705 · Cited by 78
Conserved sequence elements associated with exon skipping
Miriami, E. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg279 · Cited by 75
An Intronic Splicing Enhancer Element in Survival Motor Neuron (SMN) Pre-mRNA
Miyaso, H., Okumura, M., Kondo, S., Higashide, S., Miyajima, H., & Imaizumi, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209271200 · Cited by 70
A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10
Yu, Q., Guo, J. F., & Zhou, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02477.x · Cited by 67
Modification of Alternative Splicing by Antisense Therapeutics
Kole, R., Vacek, M. M., & Williams, T. (2004) · Oligonucleotides · doi:10.1089/154545704322988067 · Cited by 53
The Regulation and Regulatory Activities of Alternative Splicing of the SMN Gene
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.i4.30 · Cited by 51
Self-citationp59fyn-mediated phosphorylation regulates the activity of the tissue-specific splicing factor rSLM-1
Stoß, O., Novoyatleva, T., Gencheva, M., Olbrich, M., Benderska, N., & Stamm, S. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.04.011 · Cited by 50
Huang, Y., Shin, N.-H., Sun, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4871 · Cited by 46
Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Forte, A., Cipollaro, M., Cascino, A., et al. (2005) · Current Drug Targets · doi:10.2174/1389450053344920 · Cited by 33
Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene
Park, V. M., Kenwright, K. A., Sturtevant, D. B., & Pivnick, E. K. (1998) · Human Genetics · doi:10.1007/s004390050837 · Cited by 29
Another step forward for SELEXive splicing
Buratti, E., & Baralle, F. E. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.11.007 · Cited by 16
Transport of Antisense Across the Blood–Brain Barrier
Jaeger, L., & Banks, W. A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-854-4:237 · Cited by 5
Cited by
The human splicing code reveals new insights into the genetic determinants of disease
Xiong, H. Y., Alipanahi, B., Lee, L. J., Bretschneider, H., Merico, D., Yuen, R. K. C., Hua, Y., Gueroussov, S., Najafabadi, H. S., Hughes, T. R., et al. (2015) · Science · doi:10.1126/science.1254806 · Cited by 1,220
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
Wang, Z., & Burge, C. B. (2008) · RNA · doi:10.1261/rna.876308 · Cited by 1,086
Finkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31408-8 · Cited by 1,019
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Kim, J., Hu, C., Moufawad El Achkar, C., Black, L. E., Douville, J., Larson, A., Pendergast, M. K., Goldkind, S. F., Lee, E. A., Kuniholm, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813279 · Cited by 827
Metadata
- Authors
- Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2006-02-01
- Volume
- 26
- Issue
- 4
- Pages
- 1333-1346
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2152766938
- Cited by
- 454
- References
- 62
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.